The Technical Analyst
Science 37 Holdings, Inc. [SNCE]
Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
Science 37 Holdings, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.35% $5.75
America/New_York / 11 mar 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 34.66 mill |
| EPS: | -21.40 |
| P/E: | -0.269 |
| Earnings Date: | May 12, 2024 |
| SharesOutstanding: | 6.03 mill |
| Avg Daily Volume: | 0.0546 mill |
| RATING 2024-03-11 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.269 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.269 | industry: PE -4.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 5.63 - 5.87 ( +/- 2.14%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-12 | Thermo Fisher Scientific Inc. | Sell | 868 990 | Common Stock |
| 2024-03-12 | Faulkner Robert C. | Sell | 26 791 | Common Stock |
| 2024-03-12 | Faulkner Robert C. | Sell | 2 068 | Stock Options (Right to Buy) |
| 2024-03-12 | Redmile Group, Llc | Sell | 2 068 | Stock Options (Right to Buy) |
| 2024-03-12 | Redmile Group, Llc | Sell | 1 017 203 | Common Stock |
| INSIDER POWER |
|---|
| -22.01 |
| Last 100 transactions |
| Buy: 7 690 094 | Sell: 9 947 934 |
Forecast:
01:40 - $5.50
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $5.75 (0.35% ) |
| Volume | 0.0488 mill |
| Avg. Vol. | 0.0546 mill |
| % of Avg. Vol | 89.46 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SNCE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SNCE
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
Latest Press Releases
2024-04-17 08:00:00 - Press Release
Science 37 Provides Fully Consented Patients To Sites To Supplement Enrollment
Research triangle park, n.c., april 17, 2024 (globe newswire) -- science 37 holdings, inc., the clinical research industry's leading metasitetm, today announced the launch of a stand-alone patient recruitment solution to deliver patients to sites that are eligible, medically reviewed, and fully consented.
2024-03-12 06:45:00 - Press Release
Emed Completes Tender Offer For All Outstanding Shares Of Science 37
Miami , march 12, 2024 /prnewswire/ -- emed, llc ("emed") today announced the successful completion of the previously announced tender offer by its wholly-owned subsidiary, marlin merger sub corporation ("purchaser"), for all the outstanding shares of common stock, par value $0.0001 per share, of science 37 holdings, inc. (nasdaq: snce) ("science 37") at a price of usd 5.75 per share. continental stock transfer & trust company, the depositary for the tender offer, has advised purchaser that, as of 12:00 midnight, new york city time, at the end of the day of monday, march 11, 2024 (the "expiration time"), the expiration of the tender offer, (i) 4,715,950 shares were validly tendered and not withdrawn in the tender offer, representing approximately 77...
2024-02-27 15:55:00 - Press Release
Science 37 Holdings Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Science 37 Holdings, Inc. - Snce
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of science 37 holdings, inc. (nasdaqcm: snce) to emed, llc. under the terms of the proposed transaction, shareholders of science 37 will receive $5.75 in cash for each share of science 37 that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether.
2024-02-12 07:45:00 - Press Release
Emed Commences Tender Offer For Science 37
Miami , feb. 12, 2024 /prnewswire/ -- emed, llc ("emed") today announced that its wholly-owned subsidiary, marlin merger sub corporation, a delaware corporation ("purchaser"), has commenced a cash tender offer to purchase all the outstanding shares of common stock, par value $0.0001 per share, of science 37 holdings, inc. (nasdaq: snce) ("science 37") for a price of $5.75 per share (the "offer"). the offer is being made upon the terms and subject to the conditions set forth in the offer to purchase, dated february 12, 2024 and the related letter of transmittal and pursuant to the terms of the previously announced agreement and plan of merger, dated as of january 28, 2024 (the "merger agreement"), among emed, purchaser and science 37.
2024-02-10 11:08:00 - Press Release
Science 37 Holdings Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Adequacy Of Price And Process In Proposed Sale Of Science 37 Holdings, Inc. - Snce
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of science 37 holdings, inc. (nasdaqcm: snce) to emed, llc. under the terms of the proposed transaction, shareholders of science 37 will receive $5.75 in cash for each share of science 37 that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether.
Latest News
2023-11-12 00:51:06 - Seeking Alpha
Science 37 Holdings, Inc. (SNCE) Q3 2023 Earnings Call Transcript
Science 37 Holdings, Inc. (NASDAQ:SNCE ) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Steve Halper - Investor Relations David Coman - Chief Executive Officer Mike Zaranek - Chief Financial Officer Conference Call Participants Charles Rhyee - Cowen and Company Matt Hewitt - Craig-Hallum Christine Rains - William Blair Nelson Cox - Lake Street Operator Greetings and welcome to the Science 37 Third Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
2023-10-24 06:00:00 - GlobeNewsWire
Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023
RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report third quarter 2023 financial results prior to the market open on Tuesday, November 7, 2023.
2023-09-05 08:00:00 - GlobeNewsWire
Science 37 to Participate in H.C. Wainwright 25th Annual Global Investment Conference
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023.
2023-08-12 13:57:09 - Seeking Alpha
Science 37 Holdings, Inc. (SNCE) Q2 2023 Earnings Call Transcript
Science 37 Holdings, Inc. (NASDAQ:SNCE ) Q2 2023 Results Conference Call August 8, 2023 8:30 AM ET Company Participants Steven Halper - LifeSci Advisors David Coman - CEO Mike Zaranek - CFO Conference Call Participants Frank Takkinen - Lake Street Capital Markets Christine Rains - William Blair Matt Hewitt - Craig-Hallum Capital Group Operator Greetings, and welcome to the Science 37 Second Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
2023-08-09 11:36:21 - PennyStocks
Best Penny Stocks To Buy This Week? 3 Under $0.99 To Watch
Are you on the hunt for the best penny stocks to buy right now? If so, you're part of a growing community of traders.
2023-05-01 07:00:00 - GlobeNewsWire
Science 37 to Report First Quarter 2023 Financial Results on May 15, 2023
RESEARCH TRIANGLE PARK, N.C., May 01, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report first quarter 2023 financial results prior to the market open on Monday, May 15, 2023.
2023-03-13 08:41:32 - InvestorPlace
Why Is Science 37 (SNCE) Stock Up 9% Today?
Science 37 (NASDAQ: SNCE ) stock is rising higher on Monday following news of inducement equity awards for its Metasite employees. According to a press release from Science 37, the awards were approved by its Board of Directors in November 2022.
2023-02-23 08:30:00 - GlobeNewsWire
Science 37 to Present at the Cowen 43rd Annual Health Care Conference
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming Cowen 43rd Annual Health Care Conference in Boston.
2023-02-21 08:30:00 - GlobeNewsWire
Science 37 to Report Fourth Quarter 2022 Financial Results on March 6, 2023
RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report fourth quarter 2022 financial results prior to the market open on Monday, March 6, 2023.
2022-11-30 16:05:00 - GlobeNewsWire
Science 37 to Present at the 5ᵗʰ Annual Evercore ISI HealthCONx Conference
RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming 5th Annual Evercore ISI HealthCONx Conference.